Hostname: page-component-586b7cd67f-l7hp2 Total loading time: 0 Render date: 2024-11-25T10:01:47.280Z Has data issue: false hasContentIssue false
  • English
  • Français

Evaluation of a New Tranquillizer—WY 4036—in the Treatment of Anxiety

Published online by Cambridge University Press:  29 January 2018

Ijaz Haider
Ijaz Haider*
Affiliation:
Professorial Unit, Welsh National School of Medicine, Department of Psychological Medicine, Whitchurch Hospital, Cardiff
Get access Rights & Permissions [Opens in a new window]

Extract

The use of 1, 4 benzodiazepine drugs in the treatment of anxiety is well known and quite popular. The range of these drugs so far in clinical use includes chlordiazepoxide (Librium), diazepam (Valium), oxazepam (Serenid D) and nitrazepam (Mogadon). All have the advantages that effect is produced rapidly, side effects are of infrequent occurrence, and there is a very high safety factor.

Type
Research Article
Information
The British Journal of Psychiatry , Volume 119 , Issue 553 , December 1971 , pp. 597 - 598
Copyright
Copyright © Royal College of Psychiatrists, 1971 

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Hamilton, M. (1959). British Journal of Medical Psychology, 32, 50 Google Scholar
Submit a response

eLetters

No eLetters have been published for this article.